T cell–specific OSR2-KO mice demonstrated reduced exhaustion of tumor-infiltrating CD8+ T cells and CAR-T cells in the MC38 colon tumor mouse model, resulting in enhanced cell proliferation and tumor control. Here, OSR2 is linked to neoplasm.